# Neurobiology and Pharmacokinets of Acute MDMA Administration

> **NCT01148342** · PHASE1 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 187 (actual)

## Conditions studied

- Substance-Related Disorders

## Interventions

- **DRUG:** MDMA
- **DRUG:** (+/-)3,4-methylenedioxymethamphetamine Hydrochloride, MDMA HCI Capsules

## Key facts

- **NCT ID:** NCT01148342
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02-10
- **Primary completion:** —
- **Final completion:** 2012-07-18
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2019-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01148342

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01148342, "Neurobiology and Pharmacokinets of Acute MDMA Administration". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01148342. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
